COVID-related multisystem inflammatory syndrome in more diagnosed children of black and Latin descent

Credit: PIXTA / CC0 public domain

Pediatric multisystem inflammatory syndrome (MIS-C) is more black and Latin than white children, according to a new observational study of 124 pediatric patients treated at the National Children’s Hospital in Washington, DC. It is said that black children are at the highest risk. Cardiac complications such as contractile myocardial dysfunction and valvular regurgitation have been found to be more common in patients with severe MIS-C. Of the 124 patients, 63 were eventually diagnosed with MIS-C and had similar symptoms, but were eventually compared to 61 patients who were considered to be controls with another diagnosis. It was.

Published in the study Pediatric journal, Researchers provide insights into key functions that distinguish MIS-C patients, provide more realistic images of disease burden in the pediatric population, for early detection of disease and optimal results. Supports treatment. COVID-related syndrome affected nearly 4,000 people Children In the United States over the past year. Early reports showed serious MIS-C-related illnesses, significant changes in treatment, and mortality. However, this study showed that early recognition and standardized treatment could almost eliminate short-term mortality.

“Such data are essential for the development of clinical trials on the long-term effects of MIS-C,” said Dr. Roberta DeBiasi, MD, lead author of Children’s National and head of the Pediatric Infectious Diseases Division. “Our study sheds light on the demographic, clinical, and biomarker characteristics of the disease, as well as viral load and virus sequencing.”

Of the 63 children with MIS-C, 52% are severely ill, with or without the virus detected, with or without the ability to meet Kawasaki disease criteria, with or without detection, etc. , An additional subtype of MIS-C has been identified. Heart abnormality. Median age (7.25 years) and gender were similar between the MIS-C cohort and the control group, but black (46%) and Latin (35%) children were in the MIS-C group, especially lifesaving. It was overrated for children in need of emergency. Cardiac complications were more common in children who became severely ill with MIS-C (55% vs. 28%). The findings also showed that MIS-C patients showed distinct cytokine characteristics with significantly higher levels of specific cytokines than controls. This may help you understand what causes the disease and which potential treatments are most effective.

In a review of viral load and antibody biomarkers, researchers found that MIS-C cases with detectable virus had lower viral load than primary SARS-CoV-2 infected cases, but had an alternative diagnosis but were detectable. I found that it was similar to the MIS-C control that was. Virus. The majority of patients with MIS-C had more detectable SARS-CoV-2 antibodies than controls. This is consistent with the current belief that MIS-C occurs as part of an excessive immune response weeks after primary COVID-19 infection.

Viral sequencing was also performed in the MIS-C cohort and compared with cases of primary COVID-19 infection in a national geographic population of children. Eighty-eight percent of the analyzed samples were classified as GH clades. This circulates early in the US and Canadian pandemics and is consistent with the high frequency of GH clades first observed in France.

“The fact that there were no significant sequence differences between our MIS-C cohort and the primary COVID cohort is that changes in host genetics and / or immune response are not virus-specific factors, but MIS-C. It suggests that it is likely to be a major determinant of how MIS-C appears. “Dr. Deviasi says,“ As new variants continue to emerge, the frequency of MIS-C. And it will be important to study their effect on severity. “

Researchers are still looking for consensus on the most effective treatments for MIS-C.recently editorial In New England Journal of Medicine, Dr. DeBiasi calls for a large, well-characterized, prospective cohort study in a single institution and a systematic and long-term follow-up of cardiac and non-cardiac outcomes in children with MIS-C. Data from these studies will be the decisive determinants of the best set of treatment guidelines for immunotherapy to treat MIS-C.

Does your child have MIS-C, COVID-19 or Kawasaki disease?

Quote: COVID-related multisystem inflammatory syndrome in more diagnosed children of black and Latin descent (June 25, 2021) is https: // Obtained from linked-multi-system on June 25, 2021-Inflammatory Syndrome-children.html

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.

COVID-related multisystem inflammatory syndrome in more diagnosed children of black and Latin descent

Source link COVID-related multisystem inflammatory syndrome in more diagnosed children of black and Latin descent

Related Articles

Back to top button